Document Detail

Successful treatment of a complicated case of neuroleptic malignant syndrome.
MedLine Citation:
PMID:  12122539     Owner:  NLM     Status:  MEDLINE    
Neuroleptic malignant syndrome (NMS) is a life-threatening reaction often related to neuroleptic drugs, characterized by rigidity, hyperthermia, altered consciousness, and fluctuating blood pressure. We present a case of NMS that followed a doubled oral dose of a drug compound: tranylcypromine sulfate, a monoamine oxidase inhibitor, and trifluoperazine (neuroleptic). The case was complicated by rhabdomyolisis and disseminated intravascular coagulation. It was treated successfully with dantrolene sodium and generous fluid therapy without using neuromuscular blocking agents or dopamine agonists.
A Lappa; M Podestà; O Capelli; A Castagna; G Di Placido; D Alampi; F Semeraro
Related Documents :
1521479 - Acrokeratosis paraneoplastica of bazex: report of a case in a young black woman.
7743239 - Congenital bone marrow failure with myelodysplasia in siblings.
2747669 - Malignant hyperthermia in a child with sleep apnea.
22996619 - Metabolic syndrome in psychiatrically hospitalized patients treated with antipsychotics...
24843059 - Eculizumab as first-line therapy for atypical hemolytic uremic syndrome.
10916689 - Nevoid basal cell carcinoma syndrome and non-hodgkin's lymphoma.
7907339 - A family pedigree exhibiting features of both multiple endocrine neoplasia type 1 and m...
23088329 - The tie retraction syndrome.
11377009 - Transient cheiro-oral syndrome due to a ruptured intracranial dermoid cyst.
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2002-06-07
Journal Detail:
Title:  Intensive care medicine     Volume:  28     ISSN:  0342-4642     ISO Abbreviation:  Intensive Care Med     Publication Date:  2002 Jul 
Date Detail:
Created Date:  2002-07-17     Completed Date:  2002-11-29     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7704851     Medline TA:  Intensive Care Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  976-7     Citation Subset:  IM    
Intensive Care Unit, M.G. Vannini Hospital, Via A. Bullicante no. 4, 00177 Rome, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Oral
Antipsychotic Agents / adverse effects
Dantrolene / therapeutic use
Disseminated Intravascular Coagulation / complications
Fluid Therapy
Infusions, Intravenous
Monoamine Oxidase Inhibitors / administration & dosage,  adverse effects
Muscle Relaxants, Central / therapeutic use
Neuroleptic Malignant Syndrome / complications,  drug therapy*
Rhabdomyolysis / complications
Tranylcypromine / administration & dosage,  adverse effects
Treatment Outcome*
Trifluoperazine / administration & dosage,  adverse effects
Reg. No./Substance:
0/Antipsychotic Agents; 0/Monoamine Oxidase Inhibitors; 0/Muscle Relaxants, Central; 117-89-5/Trifluoperazine; 155-09-9/Tranylcypromine; 7261-97-4/Dantrolene

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The effects of dexmedetomidine on the ventilatory response to hypercapnia in rabbits.
Next Document:  Luxatio cordis due to right pericardium tear, a difficult diagnosis: report of a case.